Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to Push Back on Brand Name Drug Company Profiteering Ahead of Shift to Commercial Distribution For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement ahead of a Wednesday hearing in the U.S. Senate Committee […]
More Big Pharma Companies Should Also Lower Their Insulin Prices, But Policymakers Must Address Root Cause of High Drug Prices To Secure Lasting Relief For Immediate ReleaseContact: Jon [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday in response to an announcement from Eli Lilly and Company (Lilly) that the brand name drug […]
Senate Judiciary Committee Advances Critical Legislation to Crack Down on Brand Name Drug Companies’ Anti-Competitive Tactics that Extend Monopolies and Keep Prices High For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday following the passage of the Affordable Prescriptions for Patients Act of 2023 […]
Policies Must Address Big Pharma’s Egregious Practices That Cause High Drug Prices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the following statement Tuesday on President Biden’s remarks on prescription drug prices during the State of the Union address. “CSRxP applauds the positive progress made […]
Comment Letters Highlight Key Agency Initiatives Targeting Brand Name Drug Companies’ Anti-Competitive Tactics, Outline Areas for Further Action and Collaboration For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) submitted two letters to the United States Patent and Trademark Office (USPTO) this week in response to requests […]
Broad Majorities Reject Big Pharma’s Blame Game and Want Policymakers to Advance Market-Based Solutions to Crack Down on Big Pharma’s Egregious Pricing and Anti-Competitive Practices For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released the results of a national survey conducted by Morning Consult today that […]
Brand Name Drug Companies Increase Prices on Treatments for Serious Conditions Like Cancers, Autoimmune Conditions, Seizures and More For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Thursday reacting to brand name drug companies hiking prices on 587 brand name drugs over the first two weeks of […]
Brand Name Drug Companies Continue Seeking to Price-Gouge COVID-19 Treatments and Vaccines Ahead of Transition to Commercial Market For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday in response to reports that Moderna plans to hike the price of the company’s COVID-19 vaccine from $26.36 to […]
Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging the American People at the Start of 2023 For Immediate ReleaseContact: Jon [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to reports brand name drug companies will hike prices on at least 350 prescription drugs to start the new year, […]
Hemgenix Pricing Reflects Escalating Big Pharma Trend of Setting Higher and More Out-of-Control Launch Prices on New Products For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement today in response to pharmaceutical companies CSL Behring and uniQure setting a $3.5 million price tag on […]